Company: Omega Therapeutics, Inc.
Job title: Director - Drug Product & Analytical Development
Roundtable discussion – Tackling Impurity Thresholds to Review the Required Target with an Appreciation of Degradation Impact 12:00 pm
Reviewing what ‘good’ looks like when striving for purity Correlating impurity metrics with risk of degradation Discussing realistic purity metrics to maximise control as well time efficiency Read more
day: Conference Day One